powered by multiNETT - Internet-Systementwicklung
HEIDELBERG UNIVERSITY

Davioud-Charvet 
Synthesis and mechanism of cytotoxic and antiparasitic drugs that act by perturbing the redox equilibrium of their target cells

Groupleader: Elisabeth Davioud-Charvet

Born in 1961 


Academic Training and Positions

1979-1984 Pharmacy School, Lille II University, France

1985 Approbation in Pharmacochemistry

1988 PhD degree in Pharmacochemistry, Paris XI University, France

1989 - 1990 Postdoctoral Fellow in Biochemistry, Paris 6 University, France

1990 - 1994 Junior scientist at CNRS CR2, Laboratory of Biological Chemistry, Paris 6 University

1995 - 2001 Senior scientist at CNRS CR1, Laboratory of Chemistry of Biomolecules
co-group leader of the Team “Antiparasitic drugs”

1997 Habilitation, Lille II University, France

2001 - 2002 Visiting Research Scientist, Ann Arbor, Michigan University, USA,
College of Pharmacy (Prof. Dr. G. Kenyon) and Medical School (Prof. Dr. C. Williams Jr)

since 2001 Research Director DR2 at CNRS

since 2002 Junior Group Leader at the Heidelberg University Biochemistry Center (BZH)

since 2005 Group Leader (project B14) in the collaborative research center
Sonderforschungsbereich 544 entitled "Control of tropical infectious diseases”,
Heidelberg University

since 2008 Group Leader of the bioorganic & medicinal chemistry Team, in the research unit
UMR7509 CNRS-UdS, European School of Chemistry of Polymers and Materials
(ECPM), Strasbourg University, in double affiliation with Heidelberg University at
Biochemie-Zentrum Heidelberg (BZH).

since 2008 French representative of the COST Action CM0801 “New drugs for neglected
diseases” of the EU.


 
Informationen